The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
G ENETICS OF M YELOID L EUKEMIAS
Abstract
▪ Abstract Human leukemias are typified by acquired recurring chromosomal translocations. Cloning of these translocation breakpoints has provided important insights into pathogenesis of disease as well as novel therapeutic approaches. Chronic myelogenous leukemias (CML) are caused by constitutively activated tyrosine kinases, such as BCR/ABL, that confer a proliferative and survival advantage to hematopoietic progenitors but do not affect differentiation. These activated kinases are validated targets for therapy with selective tyrosine kinase inhibitors, a paradigm that may have broad applications in treatment of hematologic malignancies as well as solid tumors. Chromosomal translocations in acute myeloid leukemias (AML) most often result in loss-of-function mutations in transcription factors that are required for normal hematopoietic development. These latter mutations, however, are not sufficient to cause AML. The available evidence indicates that activating mutations in the hematopoietic tyrosine kinases FLT3 and c-KIT, and in N-RAS and K-RAS, confer proliferative advantage to hematopoietic progenitors and cooperate with loss-of-function mutations in hematopoietic transcription factors to cause an acute leukemia phenotype characterized by proliferation and impaired differentiation. The data supporting this hypothesis and the clinical and therapeutic implications of these observations are reviewed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Druker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J. M., Lydon, N. B., Kantarjian, H., Capdeville, R., Ohno-Jones, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441401 · Cited by 5,243
Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification
Gorre, M. E., Mohammed, M., Ellwood, K., Hsu, N., Paquette, R., Rao, P. N., & Sawyers, C. L. (2001) · Science · doi:10.1126/science.1062538 · Cited by 3,104
Druker, B. J., Sawyers, C. L., Kantarjian, H., Resta, D. J., Reese, S. F., Ford, J. M., Capdeville, R., & Talpaz, M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441402 · Cited by 2,713
Joensuu, H., Roberts, P. J., Sarlomo-Rikala, M., Andersson, L. C., Tervahartiala, P., Tuveson, D., Silberman, S. L., Capdeville, R., Dimitrijevic, S., Druker, B., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441404 · Cited by 2,037
Okuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G., & Downing, J. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80986-1 · Cited by 1,856
Kottaridis, P. D., Gale, R. E., Frew, M. E., Harrison, G., Langabeer, S. E., Belton, A. A., Walker, H., Wheatley, K., Bowen, D. T., Burnett, A. K., et al. (2001) · Blood · doi:10.1182/blood.v98.6.1752 · Cited by 1,551
Wang, Q., Stacy, T., Binder, M., Marin-Padilla, M., Sharpe, A. H., & Speck, N. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3444 · Cited by 1,178
Internal tandem duplication of the flt3 gene found in acute myeloid leukemia.
Nakao, M., Yokota, S., Iwai, T., Kaneko, H., Horiike, S., Kashima, K., Sonoda, Y., Fujimoto, T., & Misawa, S. (1996) · PubMed · Cited by 1,162
Golub, T. R., Barker, G. F., Lovett, M., & Gilliland, D. G. (1994) · Cell · doi:10.1016/0092-8674(94)90322-0 · Cited by 1,155
Self-citationActivating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies
Yamamoto, Y. (2001) · Blood · doi:10.1182/blood.v97.8.2434 · Cited by 1,150
Song, W.-J., Sullivan, M. G., Legare, R. D., Hutchings, S., Tan, X., Kufrin, D., Ratajczak, J., Resende, I. C., Haworth, C., Hock, R., et al. (1999) · Nature Genetics · doi:10.1038/13793 · Cited by 1,100
Self-citationPabst, T., Mueller, B. U., Zhang, P., Radomska, H. S., Narravula, S., Schnittger, S., Behre, G., Hiddemann, W., & Tenen, D. G. (2001) · Nature Genetics · doi:10.1038/85820 · Cited by 901
Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia.
Kiyoi, H., Naoe, T., Nakano, Y., Yokota, S., Minami, S., Miyawaki, S., Asou, N., Kuriyama, K., Jinnai, I., Shimazaki, C., et al. (1999) · PubMed · doi:10.1182/blood.v93.9.3074 · Cited by 757
Fusion Between Transcription Factor CBFβ/PEBP2β and a Myosin Heavy Chain in Acute Myeloid Leukemia
Liu, P., Tarlé, S. A., Hajra, A., Claxton, D. F., Marlton, P., Freedman, M., Siciliano, M. J., & Collins, F. S. (1993) · Science · doi:10.1126/science.8351518 · Cited by 732
Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia.
Golub, T. R., Barker, G. F., Bohlander, S. K., Hiebert, S. W., Ward, D. C., Bray-Ward, P., Morgan, E., Raimondi, S. C., Rowley, J. D., & Gilliland, D. G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.4917 · Cited by 704
Self-citationPrenatal origin of acute lymphoblastic leukaemia in children
Wiemels, J., Cazzaniga, G., Daniotti, M., Eden, O., Addison, G., Masera, G., Saha, V, Biondi, A., & Greaves, M. (1999) · The Lancet · doi:10.1016/s0140-6736(99)09403-9 · Cited by 654
Whitman, S. P., Archer, K. J., Lin, F., Baldus, C. D., Becknell, B., Carlson, B. D., Carroll, A. J., Mrózek, K., Vardiman, J., George, S. L., et al. (2001) · PubMed · Cited by 633
Erickson, P., Gao, J., Chang, K., Look, T., Whisenant, E., Raimondi, S., Lasher, R., Trujillo, J., Rowley, J., & Drabkin, H. (1992) · Blood · doi:10.1182/blood.v80.7.1825.1825 · Cited by 631
Mizuki, M., Fenski, R., Halfter, H., Matsumura, I., Schmidt, R., Müller, C., Grüning, W., Kratz-Albers, K., Serve, S., Steur, C., et al. (2000) · Blood · doi:10.1182/blood.v96.12.3907 · Cited by 606
Hayakawa, F., Towatari, M., Kiyoi, H., Tanimoto, M., Kitamura, T., Saito, H., & Naoe, T. (2000) · Oncogene · doi:10.1038/sj.onc.1203354 · Cited by 579
Carroll, M., Ohno-Jones, S., Tamura, S., Buchdunger, E., Zimmermann, J., Lydon, N. B., Gilliland, D. G., & Druker, B. J. (1997) · Blood · doi:10.1182/blood.v90.12.4947 · Cited by 554
Self-citationThe t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion
Romana, S., Mauchauffe, M., Le Coniat, M., Chumakov, I., Le Paslier, D., Berger, R., & Bernard, O. (1995) · Blood · doi:10.1182/blood.v85.12.3662.bloodjournal85123662 · Cited by 530
Meshinchi, S., Woods, W. G., Stirewalt, D. L., Sweetser, D. A., Buckley, J. D., Tjoa, T. K., Bernstein, I. D., & Radich, J. P. (2001) · Blood · doi:10.1182/blood.v97.1.89 · Cited by 518
Gelmetti, V., Zhang, J., Fanelli, M., Minucci, S., Pelicci, P. G., & Lazar, M. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.12.7185 · Cited by 491
Kelly, L. M., Liu, Q., Kutok, J. L., Williams, I. R., Boulton, C. L., & Gilliland, D. G. (2002) · Blood · doi:10.1182/blood.v99.1.310 · Cited by 487
Self-citationAML1–ETO downregulates the granulocytic differentiation factor C/EBPα in t(8;21) myeloid leukemia
Pabst, T., Mueller, B. U., Harakawa, N., Schoch, C., Haferlach, T., Behre, G., Hiddemann, W., Zhang, D.-E., & Tenen, D. G. (2001) · Nature Medicine · doi:10.1038/86515 · Cited by 463
Yokota, S., Kiyoi, H., Nakao, M., Iwai, T., Misawa, S., Okuda, T., Sonoda, Y., Abe, T., Kahsima, K., Matsuo, Y., et al. (1997) · Leukemia · doi:10.1038/sj.leu.2400812 · Cited by 455
Kiyoi, H., Towatari, M., Yokota, S., Hamaguchi, M., Ohno, R., Saito, H., & Naoe, T. (1998) · Leukemia · doi:10.1038/sj.leu.2401130 · Cited by 453
Higuchi, M., O'Brien, D., Kumaravelu, P., Lenny, N., Yeoh, E.-J., & Downing, J. R. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00016-8 · Cited by 440
ETO, a Target of t(8;21) in Acute Leukemia, Interacts with the N-CoR and mSin3 Corepressors
Lutterbach, B., Westendorf, J. J., Linggi, B., Patten, A., Moniwa, M., Davie, J. R., Huynh, K. D., Bardwell, V. J., Lavinsky, R. M., Rosenfeld, M. G., et al. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.12.7176 · Cited by 434
FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia
Stirewalt, D. L., Kopecky, K. J., Meshinchi, S., Appelbaum, F. R., Slovak, M. L., Willman, C. L., & Radich, J. P. (2001) · Blood · doi:10.1182/blood.v97.11.3589 · Cited by 431
Osato, M., Asou, N., Abdalla, E., Hoshino, K., Yamasaki, H., Okubo, T., Suzushima, H., Takatsuki, K., Kanno, T., Shigesada, K., et al. (1999) · Blood · doi:10.1182/blood.v93.6.1817.406k36_1817_1824 · Cited by 397
Identification of novel FLT‐3 Asp835 mutations in adult acute myeloid leukaemia
Abu‐Duhier, F. M., Goodeve, A. C., Wilson, G. A., Care, R. S., Peake, I. R., & Reilly, J. T. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02850.x · Cited by 388
Okuda, T., Cai, Z., Yang, S., Lenny, N., Lyu, C.-J., van Deursen, J. M. A., Harada, H., & Downing, J. R. (1998) · Blood · doi:10.1182/blood.v91.9.3134 · Cited by 372
The t(8;21) Fusion Protein Interferes with AML-1B-Dependent Transcriptional Activation
Meyers, S., Lenny, N., & Hiebert, S. W. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.4.1974 · Cited by 368
Switching Signals On or Off by Receptor Dimerization
Weiss, A., & Schlessinger, J. (1998) · Cell · doi:10.1016/s0092-8674(00)81469-5 · Cited by 355
Grisolano, J. L., Wesselschmidt, R. L., Pelicci, P. G., & Ley, T. J. (1997) · Blood · doi:10.1182/blood.v89.2.376 · Cited by 352
Yergeau, D. A., Hetherington, C. J., Wang, Q., Zhang, P., Sharpe, A. H., Binder, M., Marín-Padilla, M., Tenen, D. G., Speck, N. A., & Zhang, D.-E. (1997) · Nature Genetics · doi:10.1038/ng0397-303 · Cited by 346
Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia
Kiyoi, H., Naoe, T., Yokota, S., Nakao, M., Minami, S., Kuriyama, K., Takeshita, A., Saito, K., Hasegawa, S., Shimodaira, S., et al. (1997) · Leukemia · doi:10.1038/sj.leu.2400756 · Cited by 344
Amann, J. M., Nip, J., Strom, D. K., Lutterbach, B., Harada, H., Lenny, N., Downing, J. R., Meyers, S., & Hiebert, S. W. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.19.6470-6483.2001 · Cited by 339
Wybenga-Groot, L. E., Baskin, B., Ong, S. H., Tong, J., Pawson, T., & Sicheri, F. (2001) · Cell · doi:10.1016/s0092-8674(01)00496-2 · Cited by 338
Fetal origins of the TEL-AML1 fusion gene in identical twins with leukemia
Ford, A. M., Bennett, C. A., Price, C. M., Bruin, M. C. A., Van Wering, E. R., & Greaves, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4584 · Cited by 321
FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk group
Abu-Duhier, F. M., Goodeve, A. C., Wilson, G. A., Gari, M. A., Peake, I. R., Rees, D. C., Vandenberghe, E. A., Winship, P. R., & Reilly, J. T. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02317.x · Cited by 310
Thiesing, J. T., Ohno-Jones, S., Kolibaba, K. S., & Druker, B. J. (2000) · Blood · doi:10.1182/blood.v96.9.3195 · Cited by 309
Stat5 Is Essential for the Myelo- and Lymphoproliferative Disease Induced by TEL/JAK2
Schwaller, J., Parganas, E., Wang, D., Cain, D., Aster, J. C., Williams, I. R., Lee, C.-K., Gerthner, R., Kitamura, T., Frantsve, J., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00067-8 · Cited by 303
Self-citationHe, L.-Z., Tolentino, T., Grayson, P., Zhong, S., Warrell, R. P., Rifkind, R. A., Marks, P. A., Richon, V. M., & Pandolfi, P. P. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11537 · Cited by 303
Castilla, L. H., Garrett, L., Adya, N., Orlic, D., Dutra, A., Anderson, S., Owens, J., Eckhaus, M., Bodine, D., & Liu, P. P. (1999) · Nature Genetics · doi:10.1038/13776 · Cited by 302
Castilla, L. H., Wijmenga, C., Wang, Q., Stacy, T., Speck, N. A., Eckhaus, M., Marín-Padilla, M., Collins, F. S., Wynshaw-Boris, A., & Liu, P. P. (1996) · Cell · doi:10.1016/s0092-8674(00)81388-4 · Cited by 284
Rombouts, W., Blokland, I., Löwenberg, B., & Ploemacher, R. (2000) · Leukemia · doi:10.1038/sj.leu.2401731 · Cited by 277
The t(12;21) Translocation Converts AML-1B from an Activator to a Repressor of Transcription
Hiebert, S. W., Sun, W., Nathan Davis, J., Golub, T., Shurtleff, S., Buijs, A., Downing, J. R., Grosveld, G., Roussel, M. F., Gary Gilliland, D., et al. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1349 · Cited by 272
Westendorf, J. J., Yamamoto, C. M., Lenny, N., Downing, J. R., Selsted, M. E., & Hiebert, S. W. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.1.322 · Cited by 270
Preudhomme, C., Warot-Loze, D., Roumier, C., Grardel-Duflos, N., Garand, R., Lai, J. L., Dastugue, N., Macintyre, E., Denis, C., Bauters, F., et al. (2000) · Blood · doi:10.1182/blood.v96.8.2862 · Cited by 263
Lutterbach, B., Westendorf, J. J., Linggi, B., Isaac, S., Seto, E., & Hiebert, S. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.651 · Cited by 245
Horiike, S., Yokota, S., Nakao, M., Iwai, T., Sasai, Y., Kaneko, H., Taniwaki, M., Kashima, K., Fujii, H., Abe, T., et al. (1997) · Leukemia · doi:10.1038/sj.leu.2400770 · Cited by 209
Binns, K. L., Taylor, P. P., Sicheri, F., Pawson, T., & Holland, S. J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.13.4791-4805.2000 · Cited by 204
Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia
Neubauer, A., Dodge, R., George, S., Davey, F., Silver, R., Schiffer, C., Mayer, R., Ball, E., Wurster-Hill, D., & Bloomfield, C. (1994) · Blood · doi:10.1182/blood.v83.6.1603.1603 · Cited by 199
Sexl, V., Piekorz, R., Moriggl, R., Rohrer, J., Brown, M. P., Bunting, K. D., Rothammer, K., Roussel, M. F., & Ihle, J. N. (2000) · Blood · doi:10.1182/blood.v96.6.2277 · Cited by 198
(1995) · PubMed · Cited by 198
RAS and Leukemia: From Basic Mechanisms to Gene-Directed Therapy
Beaupre, D. M., & Kurzrock, R. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.3.1071 · Cited by 192
Levis, M., Tse, K.-F., Smith, B. D., Garrett, E., & Small, D. (2001) · Blood · doi:10.1182/blood.v98.3.885 · Cited by 189
Xu, F., Taki, T., Yang, H. W., Hanada, R., Hongo, T., Ohnishi, H., Kobayashi, M., Bessho, F., Yanagisawa, M., & Hayashi, Y. (1999) · British Journal of Haematology · doi:10.1111/j.1365-2141.1999.01284.x · Cited by 178
Peters, D. G., Hoover, R. R., Gerlach, M. J., Koh, E. Y., Zhang, H., Choe, K., Kirschmeier, P., Bishop, W. R., & Daley, G. Q. (2001) · Blood · doi:10.1182/blood.v97.5.1404 · Cited by 173
Iwai, T., Yokota, S., Nakao, M., Okamoto, T., Taniwaki, M., Onodera, N., Watanabe, A., Kikuta, A., Tanaka, A., Asami, K., et al. (1999) · Leukemia · doi:10.1038/sj.leu.2401241 · Cited by 173
Imai, Y., Kurokawa, M., Izutsu, K., Hangaishi, A., Takeuchi, K., Maki, K., Ogawa, S., Chiba, S., Mitani, K., & Hirai, H. (2000) · Blood · doi:10.1182/blood.v96.9.3154 · Cited by 172
Melnick, A. M., Westendorf, J. J., Polinger, A., Carlile, G. W., Arai, S., Ball, H. J., Lutterbach, B. A., Hiebert, S. W., & Licht, J. D. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.6.2075-2086.2000 · Cited by 168
Molecular genetics of acute myeloid leukaemia
Dash, A., & Gilliland, D. G. (2001) · Best Practice & Research Clinical Haematology · doi:10.1053/beha.2000.0115 · Cited by 166
Self-citationBoth TEL and AML-1 Contribute Repression Domains to the t(12;21) Fusion Protein
Fenrick, R., Amann, J. M., Lutterbach, B., Wang, L., Westendorf, J. J., Downing, J. R., & Hiebert, S. W. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.10.6566 · Cited by 162
Gilliland, D. G. (2001) · Current Opinion in Hematology · doi:10.1097/00062752-200107000-00001 · Cited by 161
Self-citationFenski, Flesch, Serve, Mizuki, Oelmann, Kratz‐Albers, Kienast, Leo, Schwartz, Berdel, et al. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.01831.x · Cited by 146
Kozu, T., Miyoshi, H., Shimizu, K., Maseki, N., Kaneko, Y., Asou, H., Kamada, N., & Ohki, M. (1993) · Blood · doi:10.1182/blood.v82.4.1270.1270 · Cited by 139
The inv(16) encodes an acute myeloid leukemia 1 transcriptional corepressor
Lutterbach, B. A., Hou, Y., Durst, K. L., & Hiebert, S. W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12822 · Cited by 135
Inhibition of FLT3-mediated transformation by use of a tyrosine kinase inhibitor
Tse, K.-F., Novelli, E. M., Civin, C., Böhmer, F., & Small, D. (2001) · Leukemia · doi:10.1038/sj.leu.2402199 · Cited by 116
Core-binding factor: a central player in hematopoiesis and leukemia.
Speck, N. A., Stacy, T., Wang, Q., North, T. E., Gu, T.-L., Miller, J., Binder, M., & Marin-Padilla, M. (1999) · PubMed · Cited by 114
Chromosome and Molecular Abnormalities in Myelodysplastic Syndromes
Fenaux, P. (2001) · International Journal of Hematology · doi:10.1007/bf02994004 · Cited by 114
Zimonjic, D. B., Pollock, J. L., Westervelt, P., Popescu, N. C., & Ley, T. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.24.13306 · Cited by 113
Pollock, J. L., Westervelt, P., Kurichety, A. K., Pelicci, P. G., Grisolano, J. L., & Ley, T. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.15103 · Cited by 112
Nakano, Y., Kiyoi, H., Miyawaki, S., Asou, N., Ohno, R., Saito, H., & Naoe, T. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01256.x · Cited by 110
Tomasson, M. H., Williams, I. R., Hasserjian, R. P., Udomsakdi, C., McGrath, S. M., Schwaller, J., Druker, B. J., & Gilliland, D. G. (1999) · Blood · doi:10.1182/blood.v93.5.1707 · Cited by 108
Self-citationTEL contacts multiple co-repressors and specifically associates with histone deacetylase-3
Wang, L., & Hiebert, S. W. (2001) · Oncogene · doi:10.1038/sj.onc.1204479 · Cited by 101
Cuenco, G. M., Nucifora, G., & Ren, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.030421197 · Cited by 91
Motor performance of children during treatment for acute lymphoblastic leukemia
Reinders‐Messelink, H. A., Schoemaker, M. M., Snijders, T. A. B., G�eken, L., van den Briel, M. M., B�kkerink, J. P. M., & Kamps, W. A. (1999) · Medical and Pediatric Oncology · doi:10.1002/(sici)1096-911x(199912)33:6<525::aid-mpo1>3.0.co;2-8 · Cited by 88
Histone deacetylases and transcriptional therapy with their inhibitors
Pandolfi, P. P. (2001) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800100322 · Cited by 82
TEL/PDGFβR fusion protein activates STAT1 and STAT5
Wilbanks, A. M., Mahajan, S., Frank, D. A., Druker, B. J., Gilliland, D. G., & Carroll, M. P. (2000) · Experimental Hematology · doi:10.1016/s0301-472x(00)00138-7 · Cited by 70
Self-citationMelnick, A. M., Carlile, G. W., McConnell, M. J., Polinger, A., Hiebert, S. W., & Licht, J. D. (2000) · Blood · doi:10.1182/blood.v96.12.3939 · Cited by 70
Yamamoto, K., Nakamura, Y., Nakamura, Y., Saito, K., & Furusawa, S. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02003.x · Cited by 66
NUP98 gene rearrangements and the clonal evolution of chronic myelogenous leukemia
Ahuja, H. G., Popplewell, L. L., Tcheurekdjian, L., & Slovak, M. L. (2001) · Genes Chromosomes and Cancer · Cited by 63
Signal transduction inhibition: Results from phase I clinical trials in chronic myeloid leukemia
Druker, B. J. (2001) · Seminars in Hematology · doi:10.1016/s0037-1963(01)90112-x · Cited by 53
Inhibitors of prenyl transferases
Sebti, S. M., & Hamilton, A. D. (1997) · Current Opinion in Oncology · doi:10.1097/00001622-199711000-00011 · Cited by 52
Costoya, J. A., & Pandolfi, P. P. (2001) · Current Opinion in Hematology · doi:10.1097/00062752-200107000-00006 · Cited by 51
Mouse models of acute promyelocytic leukemia
Pollock, J. L., Westervelt, P., Walter, M. J., Lane, A. A., & Ley, T. J. (2001) · Current Opinion in Hematology · doi:10.1097/00062752-200107000-00005 · Cited by 26
HIGH EXPRESSION BUT NO INTERNAL TANDEM DUPLICATION OF FLT3 IN NORMAL HEMATOPOIETIC CELLS
Ishii, E., Zaitsu, M., Ihara, K., Hara, T., & Miyazaki, S. (1999) · Pediatric Hematology and Oncology · doi:10.1080/088800199276994 · Cited by 21
Cited by
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
The Cancer Genome Atlas Research Network (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301689 · Cited by 5,078
Vardiman, J. W., Thiele, J., Arber, D. A., Brunning, R. D., Borowitz, M. J., Porwit, A., Harris, N. L., Le Beau, M. M., Hellström-Lindberg, E., Tefferi, A., et al. (2009) · Blood · doi:10.1182/blood-2009-03-209262 · Cited by 4,424
Ginestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., Jacquemier, J., Viens, P., Kleer, C. G., Liu, S., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.014 · Cited by 4,012
Döhner, H., Estey, E. H., Amadori, S., Appelbaum, F. R., Büchner, T., Burnett, A. K., Dombret, H., Fenaux, P., Grimwade, D., Larson, R. A., et al. (2010) · Blood · doi:10.1182/blood-2009-07-235358 · Cited by 3,373
Applying the principles of stem-cell biology to cancer
Pardal, R., Clarke, M. F., & Morrison, S. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1232 · Cited by 1,624
Metadata
- Authors
- Kelly, L. M., & Gilliland, D. G.
- Venue
- Annual Review of Genomics and Human Genetics
- Publisher
- Annual Reviews
- Published
- 2002-09
- Volume
- 3
- Issue
- 1
- Pages
- 179-198
- ISSN
- 1527-8204 (ISSN-L)
- 1545-293X
- OpenAlex
- W2142047303
- Cited by
- 523
- References
- 92
- FWCI
- 2.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.